Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. _)
Thompson Designs, Inc.
|
(Name of Issuer)
COMMON STOCK, PAR VALUE $.001 PER SHARE
|
|
(Title of Class of Securities)
88476Q102
|
|
(CUSIP Number)
Darren Ofsink, Esq.
Ofsink, LLC
900 Third Avenue, 5th Floor
New York, New York 10022
Tel. No. (646) 627-7326
|
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 23, 2014
|
|
(Date of Event Which Requires Filing of This Statement)
|
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No. 88476Q102
|
13D
|
Page 2 of 5 Pages
|
|
1
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
James Pekarsky
|
||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) o
(b) o
|
||
|
3
|
SEC USE ONLY
|
||
|
4
|
SOURCE OF FUNDS*
OO
|
||
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO IT
EM 2(d) or 2(e) o
|
||
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
|
||
|
NUMBER OF
SHARES
|
7
|
SOLE VOTING POWER
2,500,000
|
|
|
BENEFICIALLY
OWNED BY
|
8
|
SHARED VOTING POWER
0
|
|
|
EACH
REPORTING
|
9
|
SOLE DISPOSITIVE POWER
2,500,000
|
|
| PERSON
WITH
|
10
|
SHARED DISPOSITIVE POWER
0
|
|
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,500,000
|
||
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
||
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
27.7%
|
||
|
14
|
TYPE OF REPORTING PERSON*
IN
|
||
|
CUSIP No. 88476Q102
|
13D
|
Page 3 of 5 Pages
|
Item 1. Security and Issuer.
This Statement on Schedule 13D relates to the shares of common stock, par value $0.001 per share (the “Common Stock”), of Thompson Designs, Inc., a Nevada corporation (the “Company”) and is being filed pursuant to Rule 13d-1 under the Securities Exchange Act of 1934, as amended (the “Act”). The principal executive office and mailing address of the Company is 1098 Hamilton Court, Menlo Park, California 94025.
Item 2. &#
xA0; Identity and Background.
(a) This Statement on Schedule 13D is filed by James Pekarsky (the "Reporting Person").
(b) The business address of the Reporting Persons is 1098 Hamilton Court, Menlo Park, California 94025.
(c) Mr. Pekarsky is the Chief Executive Officer, Chief Financial Officer and a director of the Company.
(d) & (e) During the last five years, the Reporting Person has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) nor during that time has the Reporting Person been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which resulted in a judgment, decree or final order enjoining the Reporting Person from future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or any finding of any violation with respect to such laws.
(f) Mr. Pekarsky is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
On January 23, 2014, the Company consummated a share exchange transaction (the “Share Exchange”) with the shareholders of BioPharmX Inc., a Delaware corporation (“BPMX”), whereby the Company issued to shareholders of BPMX an aggregate of 7,025,000 shares of Common Stock in consideration for the shares of BPMX held by them. After the share exchange, BPMX became a 100% owned subsidiary of the Company. As a result of the Share Exchange, the Reporting Person acquired 2,500,000 shares of Common Stock.
Item 4. Purpose of Transaction.
The shares of Common Stock described in Item 3 herein were acquired as a result of the Share Exchange.
The Reporting Person has no plans or proposals which would relate to or result in:
|
|
(a)
|
The acquisition by any person of additional securities of the Company, or the disposition of securities of the Company;
|
|
|
(b)
|
An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries;
|
|
|
(c)
|
A sale or transfer of a material amount of assets of the Company or any of its subsidiaries;
|
|
|
(d)
|
Any change in the present board of directors or management of the Company, including any plans or proposals to change the number or terms of directors or to fill any existing vacancies on the board;
|
|
|
(e)
|
Any material change in the present capitalization or dividend policy of the Company;
|
|
|
(f)
|
Any other material change in the Company's business or corporate structure;
|
|
|
(g)
|
Changes in the Company's charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Company by any person;
|
|
CUSIP No. 88476Q102
|
13D
|
Page 4 of 5 Pages
|
|
|
(h)
|
Causing a class of securities of the Company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;
|
|
|
(i)
|
A class of equity securities of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or
|
|
|
(j)
|
Any action similar to any of those enumerated above.
|
The Reporting Person reserves the right from time to time to acquire or dispose of shares of Common Stock, or to formulate other purposes, plans or proposals regarding the Company or securities of the Company held by the Reporting Person to the extent deemed advisable in light of general investment policies, market conditions and other factors.
Item 5. Interest in Securities of the Issuer.
(a),(b) As of the date hereof, the Reporting Person may be deemed to beneficially own 2,500,000 shares of Common Stock which represent approximately 27.7% of 9,025,000 shares of Common Stock outstanding as of the date of this report.
(c) Other than transactions in the shares of Common Stock reported herein, no transactions in the Common Stock were effected during the past sixty days by the Reporting Person.
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
Other than as disclosed in Items 3, 4 and 5, to the knowledge of the Reporting Person there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and among such persons and any other person with respect to any securities of the Company, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
Item 7. Material to be Filed as Exhibits.
None.
|
CUSIP No. 88476Q102
|
13D
|
Page 5 of 5 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Date: January 30, 2014